Clarity Pharmaceuticals Ltd (CLRPF)

Arcadium Lithium Revenue

Clarity Pharmaceuticals had revenue of 4.69M AUD in the half year ending December 31, 2024, a decrease of -18.22%. This brings the company's revenue in the last twelve months to 10.78M, up 13.61% year-over-year. In the fiscal year ending June 30, 2024, Clarity Pharmaceuticals had annual revenue of 11.51M with 17.41% growth.

• Revenue (ttm): 10.78M AUD
• Revenue Growth: +13.61%
• P/S Ratio: 160.49
• Revenue / Employee: 215.54K AUD
• Employees: 50
• Market Cap: 1.07B USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	11.51M	1.71M	17.41%
Jun 30, 2023	9.80M	3.34M	51.74%
Jun 30, 2022	6.46M	3.26M	102.06%
Jun 30, 2021	3.20M	407.65K	14.62%
Jun 30, 2020	2.79M	145.32K	5.50%